1474-14-2

Basic information

• Product Name: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)
• Synonyms: Pregn-5-ene-20-carboxylic acid, 3- (acetyloxy)-, (3.beta.,20S)-
• CAS NO: 1474-14-2
• Molecular Formula: C₂₄H₃₆O₄
• Molecular Weight: 388.5402
• Mol File: 1474-14-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 506.8°C at 760 mmHg
• Flash Point: 166.4°C
• Density: 1.13g/cm³
• Vapor Pressure: 1.21E-11mmHg at 25°C
• Refractive Index: 1.544
• CAS DataBase Reference: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)(1474-14-2)
• EPA Substance Registry System: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)(1474-14-2)

Safety Data

• Hazardous Substances Data: 1474-14-2(Hazardous Substances Data)

Usage

General Description

The chemical "(2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)" is a complex molecule with a cyclopenta[a]phenanthrene backbone and a propanoic acid side chain. The molecule contains multiple methyl groups and an acetyloxy group, which is a functional group derived from acetic acid. It is a steroid derivative and has potential pharmaceutical applications, particularly in the field of hormone therapy. This chemical's non-preferred name indicates that it may not be commonly used or recognized by the scientific community, and a more standardized nomenclature may be preferable for clear communication within the scientific community.

Upstream product

• 55509-37-0 3β-acetoxy-23,24-bisnor-chol-5-en-22-ol 
• 7726-95-6 bromine 
• 64-19-7 acetic acid 
• 5255-17-4 3β-hydroxy-5-cholenoic acid 
• 20231-57-6 methyl 5-cholenoate 
• 10211-88-8 (20S)-3β-acetoxybisnorchol-5-en-22-al 
• 10211-88-8 (20S)-3β-acetoxybisnorchol-5-en-22-al 
• 4651-48-3 stigmasterol acetate 
• 83-48-7 Stigmasterol 
• 4651-48-3 acetic acid stigmasteryl ester 
• 514-50-1 3β-acetoxy-5α,6β-dibromocholestane 
• 34751-25-2 3β-acetoxy-24-nor-chol-5-en-23-oic acid 
• 19408-50-5 3β-Hydroxy-23,24-bisnorchol-5-en-22-oic Acid 
• 69454-96-2 methyl 3β-hydroxy-24-nor-5-cholen-23-oate 

Downstream Products

• 58526-32-2 3β-acetoxy-20(S)-5α-bisnorcholanic acid 
• 67711-02-8 3β-acetoxy-23,24-dinorchol-5-en-22-oyl chloride 
• 288256-94-0 (S)-2-((3S,8S,9S,10R,13S,14S,17R)-3-Acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-propionic acid 4-nitro-phenyl ester 
• 913338-75-7 5-[2-(3-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-propionylamino]-2-benzyloxycarbonylamino-pentanoic acid 
• 913338-69-9 5-[2-(3-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-propionylamino]-pentanoic acid methyl ester 
• 913338-71-3 7-[2-(3-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-propionylamino]-heptanoic acid methyl ester 
• 75716-75-5 (R)-3-{(1R,3aR,7aR)-4-[(Z)-2-((S)-5-Hydroxy-2-methyl-cyclohex-1-enyl)-vinyl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-1-yl}-butyric acid methyl ester 
• 75716-76-6 (R)-methyl 3-((1R,3aS,7aR,E)-4-((Z)-2-((S)-5-hydroxy-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)butanoate 
• 71204-89-2 1α,3β-dihydroxy-9,10-seco-24-norchola-5,7-10(19)-trien-23-oic acid 
• 71203-48-0 methyl 1α,3β-dihydroxy-9,10-seco-24-norchola-5,7-10(19)-trien-23-oate 
• 75731-72-5 (R)-3-{(1R,3aS,7aR)-7a-Methyl-4-[2-[(S)-2-methylene-5-(toluene-4-sulfonyloxy)-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-octahydro-inden-1-yl}-butyric acid methyl ester 
• 75716-72-2 (R)-3-{(1R,3aS,7aR)-4-[2-[(3S,5R)-5-Acetoxy-3-hydroxy-2-methylene-cyclohex-(E)-ylidene]-eth-(Z)-ylidene]-7a-methyl-octahydro-inden-1-yl}-butyric acid methyl ester 
• 75716-71-1 (R)-3-{(1R,3aS,7aR)-4-[2-[(3S,5R)-5-Acetoxy-3-hydroxy-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-butyric acid methyl ester 
• 85179-02-8 3β-acetoxy-23,24-dinor-chol-5-en-22-oic acid amide 

Relevant articles and documents

-

-

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, wherein Z is a group of the formula (i), (ii), (iii), (iv), or (v), and wherein L1, L2, L3, X1, X2, Y, Rz4, Rz5, Rz6, n, R1, R2, R3a, R3b, R4a, R4b, R6a, R6b, R7a, R7b, R11a, R11b, R14, R17, R19, R20, R23a, R23b, and R24 are as defined herein, and pharmaceutical compositions thereof. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions in mammals.